Emami Ltd surged over 90% to break a 9-year consolidation, hitting a fresh high of Rs 844. Experts suggest further gains with a target abov...

Axiom Ayurveda has a manufacturing facility in Ambala, Haryana, and is setting up a new state-of-the-art facility in Jammu at a cost Rs 160...

Emami is one of the leading and fastest-growing personal and healthcare businesses in India, with an enviable portfolio of household brand ...

Promoters held 54.27 per cent stake in the company as of 31-Dec-2022, while FIIs owned 11.14 per cent, DIIs 27.0 per cent.

GM is expected to improve sequentially but operating margin will remain under pressure owing to weak revenue show. The brokerage models 15%...

For the quarter ended 30-09-2022, the company has reported a Consolidated Total Income of Rs 855.74 Crore, up 9.06 % from last quarter Tota...

The global investment bank expects Emami's growth to recover from H2FY23 after a very high base. Margin pressures will persist in the near ...

Emami Ltd., incorporated in the year 1983, is a Mid Cap company (having a market cap of Rs 20453.92 Crore) operating in FMCG sector.

They have, however, cheered the skincare products maker's acquisition of the Dermicool brand from Reckitt Benkiser, which will make it a ma...

Buy Emami Ltd. with a target of Rs 1150 and a stop loss of Rs 985

Buy Emami Ltd. at a price target of Rs 1210 and a stop loss at Rs 1060 from entry point

Buy Emami Ltd. at a price target of Rs 1217.0 and a stop loss at Rs 1148.0 from entry point

Buy Emami Ltd. at a price target of Rs 1360.0 and a stop loss at Rs 1110.0 from entry point

Buy Emami Ltd. at a price target of Rs 1260.0 and a stop loss at Rs 1080.0 from entry point

Buy Emami Ltd. at a price target of Rs 1360.0 and a stop loss at Rs 1080.0 from entry point

Buy Emami Ltd. at a price target of Rs 1360 and a stop loss at Rs 1080

Buy Emami Ltd. at a price target of Rs 1180 and a stop loss at Rs 1112